NAUTILUS BIOTECHNOLOGY INC (NAUT)

US63909J1088 - Common Stock

2.69  +0.02 (+0.75%)

After market: 2.69 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
79.71M76.15M63.62M50.50M15.74M
Research and Development
48.81M45.45M36.47M28.35M12.43M
Selling, General, and Administrative Expenses
30.39M28.90M25.95M21.15M3.31M
Operating Income
-79.71M-76.15M-63.62M-50.50M-15.74M
Interest Income/Expense
12.33M12.55M5.82MN/A50.00K
Other Income/Expense
-66.00K-73.00K-120.00K180.00K130.00K
Income Before Taxes
-67.44M-63.67M-57.92M-50.32M-15.62M
Net Income
-67.44M-63.67M-57.92M-50.32M-15.62M
EBITDA
-77.73M-74.30M-62.40M-49.48M-15.03M
 
Per Share Data
EPS Diluted Total Ops
-0.55-0.51-0.46-0.40-0.13
Non GAAP EPS
-0.55-0.52-0.47N/AN/A
 
Statistics

All data in USD

Charts